Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Retinitis Pigmentosa (Retinitis) 36
May 02, 2018: miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases 36
Apr 26, 2018: GenSight Biologics to Present Data on GS030 at the Annual Meeting of Association for Research in Vision and Ophthalmology Annual Meeting 36
Clinical Trial Profile Snapshots 37
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 93

List of Tables
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17
Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21
Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

List of Figures
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16
Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Retinitis Pigmentosa (Retinitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Retinitis Pigmentosa (Retinitis) to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 20
Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Retinitis Pigmentosa (Retinitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Retinitis Pigmentosa (Retinitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Retinitis Pigmentosa (Retinitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Retinitis Pigmentosa (Retinitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 92

Companies Mentioned
- Novelion Therapeutics Inc
- Neurotech Holdings LLC
- Allergan Plc
- Ocugen Inc
- Nacuity Pharmaceuticals Pty Ltd
- jCyte Inc
- Innovations In Sight LLC
- Horama SA
- Dompe Farmaceutici SpA
- CMAX